DigestRedComo funciona
Red
/
Empresas
Se
No verificado

Seismic Therapeutic, Inc.

Sobre qué escribimos

BiotecnologíaEventosFarmacéuticaIndustriaSalud

15 Comunicados de prensa

Ver todos los comunicados de prensa
02/06/2025
Seismic Therapeutic Appoints Sophie Jones, M.D., as Chief Financial Officer
Fuente
Seismic Therapeutic, Inc.
Editor
Business Wire
1.00
0
10/04/2025
Industria
Salud
Medicina - Varios
Ciencia
Farmacéutica
Biotecnología
Seismic Therapeutic Doses First Cohort in Phase 1 Clinical Trial of S-4321, a Novel Bifunctional Antibody that Agonizes PD-1 and FcγRIIb Inhibitory Receptors for the Treatment of Autoimmune Disease
Fuente
Seismic Therapeutic, Inc.
Editor
Business Wire
1.00
0
18/03/2025
Mercado laboral
Biotecnología
Salud
Farmacéutica
Medicina - Varios
Seismic Therapeutic Forms Translational Medicine Advisory Board with Prominent Experts in Immunology, Rheumatology, Dermatology and Neurology
Fuente
Seismic Therapeutic, Inc.
Editor
Business Wire
1.00
0
11/03/2025
Industria
Técnica
Ciencia
Medicina - Varios
Biotecnología
Salud
Farmacéutica
Seismic Therapeutic Doses First Cohort in Phase 1 Clinical Trial of S‑1117, a Novel Pan‑IgG Protease Therapy for Antibody-Mediated Diseases
Fuente
Seismic Therapeutic, Inc.
Editor
Business Wire
1.00
0
28/02/2025
Salud
Medicina - Varios
Ciencia
Farmacéutica
Biotecnología
Eventos
Ferias y Congresos
Industria
Seismic Therapeutic Presents Preclinical Data on S-8484, Its Novel IgE Protease, for Treatment of Allergic Diseases
Fuente
Seismic Therapeutic, Inc.
Editor
Business Wire
1.00
0
09/12/2024
Eventos
Industria
Biotecnología
Farmacéutica
Salud
Medicina - Varios
Seismic Therapeutic Presents New Preclinical Efficacy Data for S-1117 in Prophylactic and Therapeutic Animal Models of Immune Thrombocytopenia (ITP) at 66th ASH Annual Meeting
Fuente
Seismic Therapeutic, Inc.
Editor
Business Wire
1.00
0
18/11/2024
Biotecnología
Salud
Farmacéutica
Medicina - Varios
Eventos
Industria
Seismic Therapeutic Presents New Preclinical Data for S-4321, a Next Generation PD‑1:FcγRIIb-Selective Bifunctional Agonist Antibody for the Treatment of Autoimmune Disease, at ACR Convergence 2024
Fuente
Seismic Therapeutic, Inc.
Editor
Business Wire
1.00
0
07/11/2024
Eventos
Ferias y Congresos
Biotecnología
Farmacéutica
Salud
Seismic Therapeutic to Participate in Upcoming Investor Conferences
Fuente
Seismic Therapeutic, Inc.
Editor
Business Wire
1.00
0
06/11/2024
Eventos
Industria
Tecnología de la información
Salud
Técnica
Software
Farmacéutica
Seismic Therapeutic Presents Data Demonstrating Key Capabilities and Broad Utility of Its Machine Learning-enabled IMPACT Platform to Create Novel Biologic Medicines
Fuente
Seismic Therapeutic, Inc.
Editor
Business Wire
1.00
0
05/11/2024
Eventos
Ferias y Congresos
Industria
Ciencia
Técnica
Biotecnología
Medicina - Varios
Farmacéutica
Salud
Seismic Therapeutic Announces Presentations at Upcoming Scientific and Medical Conferences
Fuente
Seismic Therapeutic, Inc.
Editor
Business Wire
1.00
0

Detalles de contacto

Redes sociales

Seguidores
0
Compatibilidad
0